| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 14,967 | 1,784 |
-
| | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit | 14,967 | 1,784 |
-
| | | Operating Expenses | | Research Development | 37,764 | 31,074 | 33,630 | | Selling General and Administrative | 19,666 | 15,278 | 12,277 | | Non Recurring |
-
|
-
|
-
| | Others | 1,493 | 1,237 | 952 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (43,956) | (45,805) | (46,859) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,819 | 4,986 | 787 | | Earnings Before Interest And Taxes | (39,137) | (40,819) | (46,072) | | Interest Expense | 218 | 348 | 273 | | Income Before Tax | (39,355) | (41,167) | (46,345) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (39,355) | (41,167) | (46,345) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (39,355) | (41,167) | (46,345) | | Preferred Stock And Other Adjustments |
-
| (351) | (19,583) | | | Net Income Applicable To Common Shares | ($39,355) | ($41,518) | ($65,928) |
|
0.51% Nasdaq 
Income Statement
